Public procurement notice: Contract Notice
Published: 2019-02-11
Buyer: London Borough of Sutton
Country: UK
Contract type: Works
Procedure: Competitive dialogue
CPV classification: 45000000: Construction work | 45100000: Site preparation work | 45111000 | 45211350 | 45213000: Construction work for commercial buildings
Estimated value: 350000000 GBP
Submission deadline: 2019-03-11
Award criteria: The most economic tender

Technical requirements: The London Borough of Sutton (LBS) is seeking a development partner, with experience in delivering high quality commercially led research and development and life science accommodation, that it can work with over the long term to deliver the vision of The London Cancer Hub.
The ambition is to create a world-leading cancer innovation centre on the Site, drawing on the pedigree of the adjacent ICR and The Royal Marsden. It will provide opportunities for scientists, clinicians, and innovative companies to come together in a world-class community built on the life science campus.
Located strategically within the UK’s life science cluster known as the “Golden Triangle”, the London Cancer Campus, referred to as the Campus, in South West London extends to 21 hectares and includes land owned by The Institute of Cancer Research (ICR) and The Royal Marsden. As part of the Campus, LBS has acquired freehold title to 4,8 hectares of land. This is referred to as “the Site” and represents the commercial opportunity for a development partner. The site has the potential to accommodate up to 100 000 m
General areas of responsibility expected to be undertaken by the development partner include, but are not limited to:
Tenders will be opened through the e-portal within an hour of the time specified in the Selection Questionnaire.
No tender received after the time and date specified in the Selection Questionnaire will be considered without the express authority of LBS's Strategic Director of Resources.
Tender opening will be carried out by a representative nominated from LBS's Corporate Procurement Unit at the time of uploading the tender onto the portal.
Option A: (non-variant bid), delivery of the first phase building, either speculatively or on a market pre-let/pre-sale, and later phases; and
Option B: (mandatory variant) which shall include delivery of the first phase building on an income strip model with the PSDP as development manager with LBS taking the pre-let and option to buy back the freehold for a nominal sum.
The nature of the Legal Arrangement between LBS and PSDP will depend on what represents the most appropriate legal solution for the Project: either an incorporated joint venture vehicle or an unincorporated contractual arrangement (e.g. development agreement).
LBS may disclose identities of Applicants responding to the SQ to the Key Stakeholders, being: the Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust and Epsom St Helier University Hospitals NHS Trust.
One of the aims of the Project will be to operate in a spirit of mutual respect, trust and confidence and to give due regard to the Key Stakeholders' values, culture and normal business as leading providers of cancer research, education and training.
Epsom St Helier University Hospitals NHS Trust may obtain development management services from the PSDP.
LBS may consider deploying the PSDP as its development manager for an alternative use if market conditions change.
The subject matter of the contract has been scoped to take into account LBS's priorities relating to economic, social and environmental well-being.

Eligibility requirements: Please refer to the Selection Questionnaire.

Award value: 350000000